Immix Biopharma, Inc. — SCHEDULE 13G Filings
2 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Immix Biopharma, Inc. (IMMX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Immix Biopharma, Inc. has filed 2 SCHEDULE 13G documents with the SEC since 2021. To view all SEC filings by Immix Biopharma, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
RW
RW WD
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001104659-26-032741 | Mar 20, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-016248 | Feb 17, 2026 | — |